|
| Patients not given chance |
2/23/2007 |
|
AMSTERDAM — Cancer patients do not always get the newest and best medicines. Limited in their budgets, hospitals often choose for cheaper, less effective medicines, research results from the Dutch Federation for Cancer Patient Organisations (NKF) show.
NFK investigated the distribution of Herceptin (a remedy against one form of breast cancer) and Velcade (used to treat Kahler’s disease).
According to NFK, most doctors agree that these are currently the best medicines on the market, but not every patient gets them as they are very pricy.
Last year alone, up to a thousand patients were deprived of the opportunity to try these medicines, Het Algemeen Dagblad reports.
[Copyright Expatica News +
|
|
|
|
|
|
|
|
|
